Log in to save to my catalogue

High background in ELISpot assays is associated with elevated levels of immune activation in HIV‐1‐s...

High background in ELISpot assays is associated with elevated levels of immune activation in HIV‐1‐s...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6113767

High background in ELISpot assays is associated with elevated levels of immune activation in HIV‐1‐seronegative individuals in Nairobi

About this item

Full title

High background in ELISpot assays is associated with elevated levels of immune activation in HIV‐1‐seronegative individuals in Nairobi

Publisher

England: John Wiley & Sons, Inc

Journal title

Immunity, Inflammation and Disease, 2018-09, Vol.6 (3), p.392-401

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Introduction
Spontaneous interferon‐γ (IFNγ) released detected by enzyme‐linked immunospot (ELISpot) assays may be a biological phenomenon. Markers of immune activation levels were assessed as correlates of high background among individuals in Kenya.
Methods
Couples concordantly seronegative for HIV‐1 were enrolled. IFN‐γ ELISpot assays we...

Alternative Titles

Full title

High background in ELISpot assays is associated with elevated levels of immune activation in HIV‐1‐seronegative individuals in Nairobi

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6113767

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6113767

Other Identifiers

ISSN

2050-4527

E-ISSN

2050-4527

DOI

10.1002/iid3.231

How to access this item